ArticleMayo Clinic proceedings2024

Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.

Yeela Talmor-Barkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.